Cargando…
Integrated Analysis of Single-Cell and Bulk RNA-Sequencing Reveals a Tissue-Resident Macrophage-Related Signature for Predicting Immunotherapy Response in Breast Cancer Patients
SIMPLE SUMMARY: Immune checkpoint therapy (ICT) has proven to be a promising therapeutic approach to breast cancer (BC), but most patients with BC do not respond to ICT and there are no validated predictive biomarkers. Therefore, it is urgently necessary to identify a valuable biomarker for predicti...
Autores principales: | Xia, Zi-An, Zhou, You, Li, Jun, He, Jiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9688720/ https://www.ncbi.nlm.nih.gov/pubmed/36428599 http://dx.doi.org/10.3390/cancers14225506 |
Ejemplares similares
-
Integrated analysis of single-cell and bulk RNA sequencing data reveals a pan-cancer stemness signature predicting immunotherapy response
por: Zhang, Zhen, et al.
Publicado: (2022) -
Integrated analysis of single-cell and Bulk RNA sequencing reveals a malignancy-related signature in lung adenocarcinoma
por: Wu, Mengxi, et al.
Publicado: (2023) -
Integration of single-cell and bulk RNA sequencing to establish a prognostic signature based on tumor-associated macrophages in colorectal cancer
por: Li, Hua, et al.
Publicado: (2023) -
Integrating bulk and single-cell RNA sequencing data reveals the relationship between intratumor microbiome signature and host metabolic heterogeneity in breast cancer
por: Chen, Fangyue, et al.
Publicado: (2023) -
Integrating single-cell and bulk RNA sequencing to predict prognosis and immunotherapy response in prostate cancer
por: Wen, Xiao Yan, et al.
Publicado: (2023)